Polypill for prevention of cardiovascular diseases

Lancet. 2020 Feb 8;395(10222):413-414. doi: 10.1016/S0140-6736(19)33002-8.

Authors

Simon B Dimmitt¹, Hans G Stampfer²

Affiliations

¹ Division of Internal Medicine, Medical School, Faculty of Health Sciences, University of Western Australia, Nedlands, WA 6009, Australia. Electronic address: simondimmitt@gmail.com.
² Division of Psychiatry, Medical School, Faculty of Health Sciences, University of Western Australia, Nedlands, WA 6009, Australia.

PMID: 32035546
DOI: 10.1016/S0140-6736(19)33002-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular Agents*
Cardiovascular Diseases*
Humans
Primary Prevention
Secondary Prevention

Substances

Cardiovascular Agents